Navigation Links
WuXi PharmaTech Announces Second-Quarter 2010 Results
Date:8/1/2010

(144) 11% (257) (94) 173% Income tax expenses 2,923 2,069 41% 5,122 3,952 30% EBITDA 23,373 22,231 5% 47,371 40,906 16% Adjustments Share-based compensation 2,748 2,659 3% 5,069 4,658 9% Mark-to-market gains (losses) from foreign-currency forward contracts (200) 401 * 416 (2,219) * Non-recurring deal costs 2,933 -- * 2,933 * Impairment charge from discontinued operations -- -- -- -- * Adjusted EBITDA 28,854 25,291 14% 55,789 43,345 29% Income attributable to holders of ADS (Non-GAAP): Basic 19,907 17,813 12% 38,214 32,015 19% Diluted 19,907 17,813 12% 38,214 32,015 19% Basic earnings per ADS (Non-GAAP) 0.29 0.26 9% 0.55 0.47 16% Diluted earnings per ADS (Non-GAAP) 0.27 0.24 10% 0.51 0.44 18% Weighted average ADS outstanding - basic 69,416,476 67,944,436 69,246,669 67,469,104 Weighted average ADS outstanding - diluted 74,591,847 73,152,798 74,465,668 73,356,170 * Not meaningful WUXI PHARMATECH (CAYMAN) INC. REVENUE BREAKDOWN (in thousands of U.S. dollars) Three Months Ended Six Months Ended June 30, June 30, 2010 2009 % 2010 2009 % Net revenues: China-based Laboratory Services 52,673 44,810 18% 102,645 86,458 19% U.S.-based Laboratory Services 19,908 16,679 19% 36,934 31,626 17% Subtotal
'/>"/>
SOURCE WuXi PharmaTech (Cayman) Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16

Related medicine technology :

1. WuXi PharmaTech RESCHEDULES Second-Quarter 2010 Earnings Conference Call
2. WuXi PharmaTech Well Positioned to Continue Growing as Independent Company; Will Receive Breakup Fee of $30 million
3. WuXi PharmaTech Appoints Hao Zhou as Chief Financial Officer
4. WuXi PharmaTech Announces First-Quarter 2010 Results
5. WuXi PharmaTech Schedules First-Quarter 2010 Earnings Release
6. WuXi PharmaTech Enters into Collaboration with J&JPRD, a division of Janssen Pharmaceutica for Preclinical Services and Training
7. WuXi PharmaTech Passes EMEA Inspection of Its GMP Manufacturing and Analytical Testing Facilities in Shanghai
8. WuXi PharmaTech Schedules Fourth-Quarter 2009 Earnings Release
9. WuXi PharmaTech Included in the Deloitte Technology Fast 500 Asia Pacific 2009 List for the Sixth Consecutive Year
10. Pharmatech, Inc. Contracts for Five New Just-in-Time Clinical Trials
11. Pharmatech Teams up With Systems Medicine LLC and the Sarcoma Foundation of America for a Phase II Myxoid Liposarcoma Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... Market by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture ... Users (Hospitals), Advanced technologies - Global Forecast to ... is poised to reach $19,786.3 Million by 2019 ... of 6.8% from 2014 to 2019. ...
(Date:9/19/2014)... RESEARCH TRIANGLE PARK, N.C. , Sept. 19, ... company focused on cloud-based drug design and development, ... strategy. The company,s mission is to design new ... Phase 1 and 2 partners to further their ... enhance its portfolio investments. To support this business ...
(Date:9/19/2014)... 2014  4WEB Medical announces the formal launch of ... osteotomy implants on the market today at this ... in Chicago .  The Osteotomy Truss ... needs with 74 size options included in one versatile ... only 15 to 18 implant sizes, which limited a ...
Breaking Medicine Technology:Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 4Cloud Pharmaceuticals Announces Partnering Sessions and Presentation Schedule 24WEB Medical Unveils 3D-Printed Osteotomy Truss System 2
(Date:9/19/2014)... Top 10 Best SEO Hosting, ... HostGator.com, GoDaddy and Bluehost are among the best ... the most recommended suppliers for webmasters from the ... high quality Linux hosting (including VPS and cloud ... of many top hosting companies that started thinking ...
(Date:9/19/2014)... (PRWEB) September 19, 2014 Singulair, developed ... physiologic actions of leukotriene D4 (LTD4). LTD4 belongs to ... a variety of cells, including mast cells and eosinophils, ... Several studies have determined that there are higher concentrations ... compared with non-asthmatic individuals. The production of CysLTs is ...
(Date:9/19/2014)... September 19, 2014 Follow ... assays used for detection and quantification of the ... sample. Driven by steady expansion in immunodiagnostics and ... global immunoassay systems market has evolved remarkably well ... such as diabetes, cardio-vascular ailments, infectious diseases, allergy ...
(Date:9/19/2014)... MD & Salt Lake City, UT (PRWEB) September 19, ... to launch the new Activz Greens Smoothie ... Products Expo East, September 18th-20th in Baltimore, MD. ... with 8 organic super foods combined in one convenient ... Natural Products Expo East, September 18th-20th in Baltimore, MD. ...
(Date:9/19/2014)... grow well in infertile land, and bear many beans ... is because most legumes have a symbiotic relationship with ... air and then supply the host plant with ammonia ... organs called nodules in their roots. However, if too ... the growth of the plants, because the energy cost ...
Breaking Medicine News(10 mins):Health News:Top10BestSEOHosting.com Announces Great Linux Web Hosting Suppliers In 2014 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 2Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 3Health News:Singulair Asthma Market to 2023 – Etiology, Pathophysiology, Diagnosis & Treatment Overview in New Report Available at LifeScienceIndustryResearch.com 4Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Growing Preference for Non-Invasive Diagnostics Spurs Growth in the Global Immunoassay Systems Market, According to New Report by Global Industry Analysts, Inc. 4Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 2Health News:New Activz Greens Smoothie with 8 Organic Superfoods & More Launched at Natural Products Expo East 3Health News:Long-distance communication from leaves to roots 2
... , , ... ANDS ) announced that it has entered into ... in gross proceeds in a "registered direct" offering through the ... estimates that net proceeds from the offering will be approximately ...
... , Supermarket Gains Latest Pharmacy Management Technology, Will Offer Patients ... Boise, Idaho-based Albertson,s, LLC has selected PDX and affiliates ... its pharmacy technology solution. , , Albertson,s, LLC ... Enterprise Pharmacy System (EPS), unparalleled in efficiency, ...
... vascular congestion is an important mediator in heart failure, ... Journal of Cardiac Failure ( http://www.onlinejcf.com/ ), ... that venous endothelium is a key regulator of central ... (HF). The present study demonstrates that in venous ...
... 4 Fora Care announces the launch of their ... their Point of Care Testing (POCT) System at the ... June 6-8 at the Ernest N. Morial Convention Center, ... patients to safely and securely upload critical blood glucose ...
... LONDON, June 4 The latest issue of ... authoritative,review on sulfonylureas by Professor Ian Campbell, a leading ... Professor Campbell,s review focuses on sulfonylurea-induced hypoglycemia,(SIH), which is ... 2 diabetes. In the review he discusses the incidence ...
... , SAN FRANCISCO, June 4 Medivation, Inc. (Nasdaq: ... and chief executive officer, will present at the 8th Annual ... a.m. Eastern Time at the New York Palace Hotel. , ... and its clinical development programs for Dimebon for Alzheimer,s and ...
Cached Medicine News:Health News:Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering 2Health News:Anadys Pharmaceuticals, Inc. Announces Pricing of Common Stock and Warrant Offering 3Health News:Albertson's, LLC Selects PDX-NHIN-Rx.com to Provide Complete Pharmacy Management Solution 2Health News:Fora Care Inc. to Launch Cost-Effective Solution for Diabetes Care at ADA 69th Scientific Sessions 2Health News:Comprehensive Review on Sulfonylureas in the Latest Issue of Diabetic Hypoglycemia (05 June 2009) 2Health News:Medivation to Present at 8th Annual Needham Life Sciences Conference 2
MONOJECT Red/Yellow Mottled Stopper...
... BD Vacutainer® SST™ Tubes ... a polymer gel for ... used for serum determinations ... provide an efficient means ...
BD Vacutainer® Specialty Tubes - Sedimentation Rate Determination (SRD)...
VACUETTE paediatric tubes have decreased sample volumes and are ideal for small childrens' veins and geriatric patients....
Medicine Products: